Ardelyx (ARDX) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.99% |
| Dec 31, 2025 | 15.11% |
| Sep 30, 2025 | 32.16% |
| Jun 30, 2025 | 35.89% |
| Mar 31, 2025 | 19.81% |
| Dec 31, 2024 | 46.43% |
| Sep 30, 2024 | 27.12% |
| Jun 30, 2024 | 62.63% |
| Mar 31, 2024 | 57.77% |
| Dec 31, 2023 | 56.57% |
| Sep 30, 2023 | 100.02% |
| Jun 30, 2023 | 60.48% |
| Mar 31, 2023 | 67.70% |
| Dec 31, 2022 | 26.78% |
| Sep 30, 2022 | -15.32% |
| Jun 30, 2022 | -35.79% |
| Mar 31, 2022 | -38.46% |
| Dec 31, 2021 | -25.62% |
| Sep 30, 2021 | -13.95% |
| Jun 30, 2021 | -5.69% |
| Mar 31, 2021 | -10.64% |
| Dec 31, 2020 | -22.41% |
| Sep 30, 2020 | 66.28% |
| Jun 30, 2020 | 57.52% |
| Mar 31, 2020 | 41.65% |
| Dec 31, 2019 | 41.70% |
| Sep 30, 2019 | -42.22% |
| Jun 30, 2019 | -39.62% |
| Mar 31, 2019 | 16.31% |
| Dec 31, 2018 | 16.10% |
| Sep 30, 2018 | 44.42% |
| Jun 30, 2018 | 39.25% |
| Mar 31, 2018 | -23.93% |
| Dec 31, 2017 | -25.91% |
| Sep 30, 2017 | -40.70% |
| Jun 30, 2017 | 5.63% |
| Mar 31, 2017 | 4.03% |
| Dec 31, 2016 | 82.25% |
| Sep 30, 2016 | 74.78% |
| Jun 30, 2016 | 4.85% |
| Mar 31, 2016 | 71.25% |
| Dec 31, 2015 | 3.11% |
| Sep 30, 2015 | 17.27% |
| Jun 30, 2015 | 20.01% |
| Dec 31, 2014 | 164.34% |